CS Analytical Laboratory, a cGMP, FDA-registered and inspected contract laboratory focused on package and container testing for the pharmaceutical, biotechnology, and medical device industries, announced on Tuesday the appointment of Jennifer Roark as director of Scientific Affairs.
In this position Roark will play a key management role in the continued growth and expansion of the CS Analytical service offering, will assist in the leadership development of key staff members, and will represent CS Analytical amongst industry groups including ASTM, USP, and PDA.
"With more than 30 years of experience in analytical chemistry and quality control testing within a cGMP environment specifically in the areas of extractables and leachables and container closure integrity testing for both pharmaceutical packaging systems and drug delivery devices, Jen brings a level of knowledge and understanding to the CS Analytical Team that can help and benefit our clients as they work to develop and qualify their package systems," said CS Analytical chief executive officer Brian Mulhall.
Roark has experience in managing groups that perform quality control testing in a cGMP environment, has been involved with numerous methods development and validation programmes, and has co-published a series of articles on analytical method validation.
BioArctic and Eisai report FDA extension of Leqembi Iqlik review
Mezzion reveals pre-IND FDA feedback on udenafil development in ADPKD
Altasciences and Certara form strategic partnership to accelerate early drug development
Xbrane resubmits FDA application for ranibizumab biosimilar after facility remediation
European Commission clears first pertuzumab biosimilar in Europe
Vanda Pharmaceuticals reports publication of imsidolimab phase III findings in NEJM Evidence
C-Ray Therapeutics' Copper-64 (Cu-64) Type II DMF gains FDA acceptance